Literature DB >> 10502801

Design of angiotensin converting enzyme inhibitors.

D W Cushman, M A Ondetti.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10502801     DOI： 10.1038/13423

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  38 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

2.  An ab initio quantum mechanical drug designing procedure: application to the design of balanced dual ACE/NEP inhibitors.

Authors:  Nishi K Rao; Arpita Yadav; Sanjeev Kumar Singh
Journal:  J Mol Model       Date:  2009-05-09       Impact factor: 1.810

3.  pH-Dependent reactivity for glycyl-L-tyrosine in carboxypeptidase-A-catalyzed hydrolysis.

Authors:  Shanshan Wu; Chunchun Zhang; Ruyin Cao; Dingguo Xu; Hua Guo
Journal:  J Phys Chem B       Date:  2011-08-05       Impact factor: 2.991

Review 4.  Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.

Authors:  G Gromo; J Mann; J D Fitzgerald
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

5.  Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.

Authors:  Julie A Kelly; Gaia A Scalabrino; Gillian R Slator; Aoife A Cullen; John F Gilmer; David G Lloyd; Geoffrey W Bennett; Karl Bauer; Keith F Tipton; Carvell H Williams
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 6.  A story of two ACEs.

Authors:  Ursula Danilczyk; Urs Eriksson; Michael A Crackower; Josef M Penninger
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

Review 7.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

8.  Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

Authors:  Michael Platten; Sawsan Youssef; Eun Mi Hur; Peggy P Ho; May H Han; Tobias V Lanz; Lori K Phillips; Matthew J Goldstein; Roopa Bhat; Cedric S Raine; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

9.  Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide.

Authors:  Soohyun Kwon; Frank Bosmans; Quentin Kaas; Olivier Cheneval; Anne C Conibear; K Johan Rosengren; Conan K Wang; Christina I Schroeder; David J Craik
Journal:  Biotechnol Bioeng       Date:  2016-08-09       Impact factor: 4.530

10.  Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.

Authors:  Venkat S R K Yedavalli; Ning Zhang; Hongyi Cai; Peng Zhang; Matthew F Starost; Ramachandra S Hosmane; Kuan-Teh Jeang
Journal:  J Med Chem       Date:  2008-08-05       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.